miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy

por Wang, Fang, Lou, Jian-fang, Cao, Yan, Shi, Xin-hui, Wang, Peng, Xu, Jian, Xie, Er-fu, Xu, Ting, Sun, Rui-hong, Rao, Jian-yu, Huang, Pu-wen, Pan, Shi-yang, Wang, Hong
Publicado 2015